ASCO guidance for stage IV EGFR-mutant NSCLC supports initial combination regimens (osimertinib plus chemotherapy; amivantamab plus lazertinib) to improve disease control relative to monotherapy.

The FLAURA2 trial showed that combining Tagrisso with chemotherapy improved survival in EGFR-mutated NSCLC, especially in patients with liver metastases and TP53 alterations. Addressing emotional and ...

Channel 13 anchors Abel Garcia and Tricia Kean share with you stories of resilience and game-changing breakthroughs for Southern Nevadans battling cancer LAS VEGAS (KTNV) — Cancer's impact is profound ...

As colon cancer rates among people younger than 50 skyrocket, a new clinical trial that uses immunotherapy, rather than ...

Author Kim Harms has written a new faith-based devotional after battling breast cancer for a second time. Her new book, "Carried Through Cancer," features the stories of over 50 women who have been ...

Cancer research this year reshaped how scientists understood, detected, and treated the disease. Researchers figured out how viral infections could reawaken dormant cancer cells, leveraged lessons ...

Today, there’s a wealth of medical information available at our fingertips online. But this ease of access comes with a danger: Many of the health claims circulating on social media aren’t true, with ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

Each month, the New York Islanders and Northwell Health are spotlighting two strong and inspiring children battling cancer in continuous support of pediatric cancer patients all season long. Siobhan O ...